Aspirin is not chemoprotective for Barrett's adenocarcinoma of the oesophagus in multicentre cohort.
Gatenby, Piers A
Aspirin is not chemoprotective for Barrett's adenocarcinoma of the oesophagus in multicentre cohort. [electronic resource] - European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) Sep 2009 - 381-4 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1473-5709
10.1097/CEJ.0b013e32832e0955 doi
Adenocarcinoma--epidemiology
Anticarcinogenic Agents--therapeutic use
Aspirin--therapeutic use
Barrett Esophagus--drug therapy
Cohort Studies
Demography
Esophageal Neoplasms--epidemiology
Female
Humans
Male
Middle Aged
Precancerous Conditions--drug therapy
Aspirin is not chemoprotective for Barrett's adenocarcinoma of the oesophagus in multicentre cohort. [electronic resource] - European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) Sep 2009 - 381-4 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1473-5709
10.1097/CEJ.0b013e32832e0955 doi
Adenocarcinoma--epidemiology
Anticarcinogenic Agents--therapeutic use
Aspirin--therapeutic use
Barrett Esophagus--drug therapy
Cohort Studies
Demography
Esophageal Neoplasms--epidemiology
Female
Humans
Male
Middle Aged
Precancerous Conditions--drug therapy